EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression. - Antin, C.; Tauziède-Espariat, A.; Debily, M.-A.; Castel, D.; Grill, J.; Pagès, M.; Ayrault, O.; Chrétien, F.; Gareton, A.; Andreiuolo, F.; Lechapt, E.; Varlet, P. (Acta Neuropathologica Communications, 2020)